BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pérez-Pérez MJ, Saiz JC, Priego EM, Martín-Acebes MA. Antivirals against (Re)emerging Flaviviruses: Should We Target the Virus or the Host? ACS Med Chem Lett 2022;13:5-10. [PMID: 35059112 DOI: 10.1021/acsmedchemlett.1c00617] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Logan A, Mazzon M, Bruce L, Barnes NM. A clinical stage LMW-DS drug inhibits infection of human cells by Dengue, Zika and Yellow Fever viruses.. [DOI: 10.1101/2022.08.31.503293] [Reference Citation Analysis]
2 Lahiri H, Arkin IT. Searching for Blockers of Dengue and West Nile Virus Viroporins. Viruses 2022;14:1750. [DOI: 10.3390/v14081750] [Reference Citation Analysis]
3 Matos MJ, Blanco MJ. Medicinal Chemistry in Portugal and Spain: A Strong Iberian Alliance. ACS Med Chem Lett 2022;13:871-2. [PMID: 35707154 DOI: 10.1021/acsmedchemlett.2c00194] [Reference Citation Analysis]
4 Wu J, Power H, Miranda-saksena M, Valtchev P, Schindeler A, Cunningham AL, Dehghani F. Identifying HSV-1 Inhibitors from Natural Compounds via Virtual Screening Targeting Surface Glycoprotein D. Pharmaceuticals 2022;15:361. [DOI: 10.3390/ph15030361] [Reference Citation Analysis]
5 Alferova VA, Mikhnovets IE, Chistov AA, Korshun VA, Tyurin AP, Ustinov AV. Perylene as a controversial antiviral scaffold. Annual Reports in Medicinal Chemistry 2022. [DOI: 10.1016/bs.armc.2022.08.001] [Reference Citation Analysis]